1. IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease.
- Author
-
Liu, Qingxiang, Zheng, Yanyan, Sturmlechner, Ines, Jain, Abhinav, Own, Maryam, Yang, Qiankun, Zhang, Huimin, Pinto E Vairo, Filippo, Cerosaletti, Karen, Buckner, Jane, Warrington, Kenneth, Koster, Matthew, Weyand, Cornelia, and Goronzy, Jörg
- Subjects
Autoimmunity ,T cell receptor ,Th2 response ,Tolerance ,Humans ,Ikaros Transcription Factor ,Ubiquitin-Protein Ligases ,Autoimmunity ,Th2 Cells ,Female ,Male ,Immunoglobulin G4-Related Disease ,Middle Aged ,Proto-Oncogene Proteins c-fyn ,Pedigree - Abstract
IgG4-related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory disease whose pathomechanisms remain poorly understood. Here, we identified gene variants in familial IgG4-RD and determined their functional consequences. All 3 affected members of the family shared variants of the transcription factor IKAROS, encoded by IKZF1, and the E3 ubiquitin ligase UBR4. The IKAROS variant increased binding to the FYN promoter, resulting in higher transcription of FYN in T cells. The UBR4 variant prevented the lysosomal degradation of the phosphatase CD45. In the presence of elevated FYN, CD45 functioned as a positive regulatory loop, lowering the threshold for T cell activation. Consequently, T cells from the affected family members were hyperresponsive to stimulation. When transduced with a low-avidity, autoreactive T cell receptor, their T cells responded to the autoantigenic peptide. In parallel, high expression of FYN in T cells biased their differentiation toward Th2 polarization by stabilizing the transcription factor JunB. This bias was consistent with the frequent atopic manifestations in patients with IgG4-RD, including the affected family members in the present study. Building on the functional consequences of these 2 variants, we propose a disease model that is not only instructive for IgG4-RD but also for atopic diseases and autoimmune diseases associated with an IKZF1 risk haplotype.
- Published
- 2024